50 results
424B5
LYEL
Lyell Immunopharma, Inc.
6 May 24
Prospectus supplement for primary offering
8:12am
and reimbursement, of LYL797, LYL845, LYL119 or any other product candidates we may develop, if approved;
our continued reliance on third parties to assist … , if approved;
the rate and degree of market acceptance, as well as the pricing and reimbursement, of LYL797, LYL845, LYL119 or any other product candidates we
S-3
EX-1.2
LYEL
Lyell Immunopharma, Inc.
28 Feb 24
Shelf registration
7:49pm
with respect to reimbursement of expenses pursuant to Section 7(g).
(f) Any termination of this Agreement shall be effective on the date specified
S-3
EX-4.5
mijaf
28 Feb 24
Shelf registration
7:49pm
S-3
6bj 72eombenl
28 Feb 24
Shelf registration
7:49pm
8-K
w6qye vq73x17y
6 Jun 23
Departure of Directors or Certain Officers
4:02pm
8-K
EX-10.1
aec4y
16 Dec 22
Lyell Immunopharma Appoints Lynn Seely, MD as President and Chief Executive Officer
4:02pm
S-3ASR
EX-4.4
jnf7yqmp6l of9bf
4 Aug 22
Automatic shelf registration
5:29pm
S-3ASR
bavfsepzis cfv
4 Aug 22
Automatic shelf registration
5:29pm